On the agenda of the seminar we put brought into discussion questions related to the implementation of TEMPUS-INOCAST project and its potential for "University - business" cooperation in scientific and educational spheres. The head of the National Scientific Laboratory, Ph.D. Erbolatuly D. started with an introductory word.
There was also a presentation of Inolab manager Pavlenko A.V. on the implementation of Tempus INOCAST international project based in EKSU. As part of the TEMPUS program INOCAST project addresses the following main objectives: the establishment of relations with the industrial enterprises of East Kazakhstan region for the production of metal products, intensification of public-private partnerships; determining the range of priority products of InoLab; the involvement of the University in the development of entrepreneurship in the region. In this case, the main purpose of InoLab is the development and implementation of research and development at JSC "Ust-Kamenogorsk Titanium Magnesium Plant" for the solution of regional problems and the sustained growth of economic development of East Kazakhstan, as well as improvement of the technological level of the enterprise and to maintain technological leadership position in steel industry. In cooperation with the company InoLab started to develop the production technology of titanium alloys used in medicine.
Speech by the Inolab researcher Kabdrakhmanova S.K. was devoted to the role of regional industrial enterprises in the implementation of the project Tempus INOCAST.
Also, the chief of department of quality products from the factory JSC “UKTMK” said that the joint project is one of the promising areas in the implementation of the strategy of industrial-innovative development on the use of titanium in Kazakhstan in medicine, because medicine is one of the fastest growing areas of titanium applications in Thus, the annual growth rate is estimated at an average of 7 - 10%. Due to the biological compatibility with the human body tissues, titanium is widely used for the manufacture of spinal implants, prosthesis joints, elements for the treatment of fractures, as well as elements of medical equipment. Also, the relevance of this area determines the growth of health care products in demand by increasing the number of elderly people aged 65 years and over, especially in developed countries, and their desire to continue to lead an active life.
This project will create a new process stages for the production of forged titanium products to be used in medical sector and improve the efficiency of health care, with the use of new technologies and equipment of the Kazakh titanium, as well as provide a way out of titanium products of JSC "UKTMK" on the domestic market and increase the share of Kazakhstan.
It is known that titanium alloys have excellent corrosion resistance and biological inertness, so they are an ideal material for producing a biologically and mechanically compatible with the human body implants, as well as high-end medical instruments.
The priority for solving problems related to the protection of public health - is the development of high-tech competitive technology for the production of medical products available that meet international standards, in particular, of biocompatible porous titanium implants for dentistry and orthopedics.
Inolab has unique prerequisites for the implementation of the first joint and extremely commercially attractive project with the participation of one of the largest enterprises of the Republic of Kazakhstan JSC "UKTMK" and leading universities of East Kazakhstan EKSTU named after D.Serikbaev and EKSU named after S.Amanzholov.
JSC "UKTMK" sells the production of high quality Ti-products, including medical alloy of Eli, which is potentially high demand in the manufacture of biocompatible implants and medical instruments, a foreign business partner, joint venture with the French company "Aubert and Duval," the company "UKAD" for the production of Ti-wires, rods, forgings.
EKSTU named after D.Serikbaev and EKSU named after S.Amanzholov have the necessary analytical and technological equipment for the project, including "Irgetas" engineering profile laboratory complexes and a national scientific laboratory of collective use. The proposed alloy processing technology is based on thermal, chemical, mechanical, ion-plasma methods of influence with the use of ovens, universal testing machines for tension and presses, the sputtering devices, lathes and other. There is a highly qualified team for the project, including eminent scientists of high international reputation and 50% of performers from among young scientists (under 35 years), among them doctors PhD and doctoral PhD, graduate and undergraduate students; they have experience in these areas, scientific reserve and international scientific communication. Experience of developers supported by the implementation of projects on similar themes within PTSF, grant funding KH MES of RK (including cooperation with scientists from the UK) and JSC “Kazakhstan sodium”; There are innovative Kazakhstan patents, inventors' certificates, publications in peer-reviewed journals, chapters in books in foreign and domestic publishing houses, monographs on topics close to the stated theme of the project.
Currently, titanium alloys and metal compositions based on them are the most effective materials for producing implants and other medical devices. From the standpoint of biocompatibility for a long time working in the living body implants is preferred to use pure titanium, which is unlike its alloy does not contain harmful to a living organism dopants usually coated passivation film has a high flexibility, but insufficient strength characteristics, in particular a cyclic durability. Consequently, more than 5% embedded implants rejected because of the development of bone tissue necrosis occurs when the surface fracture, chipping, and the penetration of metallic particles into the surrounding tissue of the body, which also limits the application of modern implants, and thus, the possibility of their use in younger patients.